Status:

UNKNOWN

Hematological Effects of Atypical Antipsychotics (AAPs) in a Geriatric Population: What is the Role of 5-HT2 Receptors

Lead Sponsor:

University Hospital, Strasbourg, France

Conditions:

Neutropenia

Eligibility:

All Genders

65+ years

Brief Summary

White lineage abnormalities and in particular neutropenia and agranulocytosis are known and increasingly studied adverse effects of antipsychotics, particularly second generation. White lineage abnorm...

Detailed Description

The investigators chose as their study population an elderly to very elderly population, hospitalized or residing in the Geriatrics center of a university hospital. Indeed, apart from resistant schizo...

Eligibility Criteria

Inclusion

  • Major subject (≥ 65 years old)
  • Subject hospitalized in Geriatric Internal Medicine, in Geriatric Follow-up Care and Rehabilitation, in a Long-Term Care Unit or Important Medical-Technical Care, in a Reinforced Accommodation Unit or in a Cognitive-Behavioral Unit at Strasbourg University Hospitals)
  • Subject not opposing the reuse of their data for the purposes of this research.
  • Indication for the introduction of the neuroleptic indicated
  • Available dosage and frequency of administration and duration of treatment

Exclusion

  • Subject having expressed opposition to participating in the study
  • Presence of a neuroleptic before admission to the University Hospitals of Strasbourg, excluding readmission of a patient included
  • Neuroleptics not present on the discharge prescription for long-term treatment
  • Neuroleptics prescribed for less than 48 hours
  • Presence of a white lineage anomaly prior to the initiation of neuroleptic treatment
  • Patient contraindicated for taking a long-term neuroleptic.
  • Hematological disease with white lineage abnormality (lymphoma, leukemia, myelodysplasia, mye syndrome

Key Trial Info

Start Date :

March 1 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 23 2024

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT06107322

Start Date

March 1 2023

End Date

March 23 2024

Last Update

October 30 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Service de Pharmacie - Stérilisation - CHU de Strasbourg - France

Strasbourg, France, 67091